Page last updated: 2024-12-04

aldicarb

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

Aldicarb: Carbamate derivative used as an insecticide, acaricide, and nematocide. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

aldicarb : The oxime carbamate resulting from the addition of 2-methyl-2-(methylsulfanyl)propanaldoxime to methyl isocyanate. A member of the class of oxime carbamate insecticides, aldicarb is a mixture of E and Z isomers; it is not known which isomer is more active. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID9570071
CHEMBL ID91732
CHEBI ID2555
SCHEMBL ID9781
MeSH IDM0000680

Synonyms (64)

Synonym
BIDD:ER0312
CHEMBL91732
BRD-K32595626-001-01-8
(1e)-2-methyl-2-(methylthio)propanal o-[(methylamino)carbonyl]oxime
aldicarbe
CHEBI:2555 ,
2-methyl-2-(methylthio)propionaldehyde o-(methylcarbamoyl)oxime
2-methyl-2-methylthio-propionaldehyd-o-(n-methyl-carbamoyl)-oxim
2-methyl-2-(methylthio)propanal, o-((methylamino)carbonyl)oxime
2-methyl-n-[(methylcarbamoyl)oxy]-2-(methylsulfanyl)propan-1-imine
propanal, 2-methyl-2-(methylthio)-, o-[(methylamino)carbonyl]oxime
SPECTRUM5_002022
BSPBIO_002463
nsc379586
nsc-379586
NCGC00090795-01
temik 10 g
oms-771
nsc 379586
propionaldehyde, 2-methyl-2-(methylthio)-, o-(methylcarbamoyl)oxime
116-06-3
aldicarb
NCGC00090795-05
NCGC00090795-04
NCGC00090795-02
NCGC00090795-03
SPECTRUM330061
NCGC00090795-07
NCGC00090795-06
inchi=1/c7h14n2o2s/c1-7(2,12-4)5-9-11-6(10)8-3/h5h,1-4h3,(h,8,10)/b9-5+
qglzxhrnayxibu-wevvvxlnsa-
bdbm50064478
[(2-methyl-2-methylsulfanylpropylidene)amino] n-methylcarbamate
NCGC00090795-09
NCGC00090795-08
NCGC00090795-10
tox21_300846
cas-116-06-3
tox21_202227
NCGC00254749-01
dtxcid1039
dtxsid0039223 ,
NCGC00259776-01
AKOS006228461
CCG-39640
2-metil-2-tiometil-propionaldeid-o-(n-metil-carbamoil)-ossima
carbamic acid, methyl-, o-((2-methyl-2-(methylthio)propylidene)amino) deriv.
temik g 10
CS-3315
HY-17529
SCHEMBL9781
aldicarb, certified reference material, tracecert(r)
2-methyl-1-(([(methylamino)carbonyl]oxy)imino)-2-(methylsulfanyl)propane #
2-methyl-2-methylthio-propionaldehyd-o-(n-methyl-carbamoyl)-oxime
temic
QGLZXHRNAYXIBU-WEVVVXLNSA-N
aldecarb
J-003379
aldicarb, pestanal(r), analytical standard
aldicarb d3
pesticide2_aldicarb_c7h14n2o2s_
mfcd00041807
Q27285799
z-isomeraldicarb

Research Excerpts

Toxicity

The toxic effects of Temik (aldicarb) on a fresh water Himalayan lake teleost, Barbus conchonius were investigated in hard and soft water. Toxicity studies have shown that channel catfish are less sensitive than rainbow trout or bluegill. The absence of statistically significant effects on any of these parameters supports earlier reports that aldicarb does not result in adverse effects on the immune system of mice.

ExcerptReferenceRelevance
" An enhanced toxic impact is indicated when the pesticides are present together rather than as individual compounds."( Individual and combined toxicity of common pesticides to teleost Puntius conchonius Hamilton.
Gill, TS; Pande, J; Tewari, H, 1991
)
0.28
" The absence of statistically significant effects on any of these parameters supports earlier reports that aldicarb does not result in adverse effects on the immune system of mice."( Aldicarb immunotoxicity: functional analysis of cell-mediated immunity and quantitation of lymphocyte subpopulations.
Baron, R; Demetral, D; Hagen, K; Ratajczak, H; Thomas, P, 1990
)
0.28
"The toxic effects of Temik (aldicarb) on a fresh water Himalayan lake teleost, Barbus conchonius were investigated in hard and soft water."( Toxicity of Temik (aldicarb) for a fresh water teleost, Barbus conchonius Hamilton.
Kumar, S; Pant, SC, 1981
)
0.26
" By regressing ordered categories of toxic severity or pathological staging on exposure dose, this method can estimate the likelihood of observing any of the categories of severity at any dose level."( Categorical regression of toxicity data: a case study using aldicarb.
Dourson, ML; Durkin, PR; Stiteler, WM; Teuschler, LK, 1997
)
0.3
"Young organisms are often more sensitive to the toxic effects of pesticides, and this finding has spurred research on further characterization of this susceptibility."( Comparison of aldicarb and methamidophos neurotoxicity at different ages in the rat: behavioral and biochemical parameters.
Moser, VC, 1999
)
0.3
" Toxicity studies have shown that channel catfish are less sensitive to the acute toxic effects of aldicarb than are rainbow trout or bluegill."( In vivo acetylcholinesterase inhibition, metabolism, and toxicokinetics of aldicarb in channel catfish: role of biotransformation in acute toxicity.
Perkins, EJ; Schlenk, D, 2000
)
0.31
" Water polluted by aldicarb and methomyl may have the potential adverse effects on the environment and human health."( [Study on genotoxicity of aldicarb and methomyl].
Jin, YT; Pang, XL; Sun, XY; Wang, J; Wang, WQ; Wu, B, 2010
)
0.36

Compound-Compound Interactions

ExcerptReferenceRelevance
"The use of polypharmacy in the present day clinical therapy has made the identification of clinical drug-drug interaction risk an important aspect of drug development process."( In Vitro Drug-Drug Interaction Potential of Sulfoxide and/or Sulfone Metabolites of Albendazole, Triclabendazole , Aldicarb, Methiocarb, Montelukast and Ziprasidone.
Giri, P; Giri, S; Gupta, L; Joshi, V; Naidu, S; Patel, N; Srinivas, NR, 2018
)
0.48
"In vitro drug-drug interaction potential of test compounds was investigated in two stages; 1) assessment of CYP450 inhibition potential of test compounds using human liver microsomes (HLM); and 2) assessment of test compounds as substrate of Phase I enzymes; including CYP450, FMO, AO and MAO using HLM, recombinant human CYP enzymes (rhCYP), Human Liver Cytosol (HLC) and Human Liver Mitochondrial (HLMit)."( In Vitro Drug-Drug Interaction Potential of Sulfoxide and/or Sulfone Metabolites of Albendazole, Triclabendazole , Aldicarb, Methiocarb, Montelukast and Ziprasidone.
Giri, P; Giri, S; Gupta, L; Joshi, V; Naidu, S; Patel, N; Srinivas, NR, 2018
)
0.48
", perpetrator and/or victim drug) to overcome any imminent risk of potential clinical drug-drug interaction when sulfoxide/sulfone metabolite(s) generating drugs are coadministered in therapy."( In Vitro Drug-Drug Interaction Potential of Sulfoxide and/or Sulfone Metabolites of Albendazole, Triclabendazole , Aldicarb, Methiocarb, Montelukast and Ziprasidone.
Giri, P; Giri, S; Gupta, L; Joshi, V; Naidu, S; Patel, N; Srinivas, NR, 2018
)
0.48

Dosage Studied

The acute effects of two carbamates (carbaryl, aldicarb) and five organophosphates (OP) were evaluated on the day of dosing at the time of peak effect. Survival times in the majority of rats dosed with a Aldicarb and receiving intravenous cyclodextrin were longer. The neuropharmacologic effects of chronic dosing with AChE inhibition could be useful for treatment of memory deficits related to CNS disorders.

ExcerptRelevanceReference
" Elimination profiles from both dosage groups demonstrate a rapid alpha phase (oral 24 hr; ip 3 hr) probably due to branchial excretion (96% after ip injection) followed by a slower beta phase (oral 107 hr; ip 28 hr) suggesting a deeper compartment such as muscle."( The distribution, elimination, and in vivo biotransformation of aldicarb in the rainbow trout (Oncorhynchus mykiss).
Buhler, DR; Erickson, DA; Lech, JJ; Schlenk, D, 1992
)
0.28
" Although the number of exposed persons was small, the increases in percentage lymphocytes and absolute numbers of CD2+ and CD8+ T cells were consistent with a dose-response relationship."( Changes in T-lymphocyte distribution associated with ingestion of aldicarb-contaminated drinking water: a follow-up study.
Anderson, HA; Belluck, D; Golubjatnikov, R; Hanrahan, L; Hong, R; Mirkin, IR, 1990
)
0.28
" The target concentration of aldicarb present in the 100 ppb dosing solution was analytically verified."( Aldicarb immunotoxicity: functional analysis of cell-mediated immunity and quantitation of lymphocyte subpopulations.
Baron, R; Demetral, D; Hagen, K; Ratajczak, H; Thomas, P, 1990
)
0.28
" The target concentration of aldicarb present in the 10 ppb dosing solution was analytically verified on a daily basis as was its stability over a 48-hr period."( Assessment of carbamate pesticide immunotoxicity.
Ratajczak, HV; Thomas, PT, 1988
)
0.27
" The target concentration of aldicarb present in the 10 ppb dosing solution was analytically verified on a daily basis as was its stability over a 48-hr period."( Evaluation of host resistance and immunity in mice exposed to the carbamate pesticide aldicarb.
Barbera, PW; Eisenberg, WC; Furedi-Machacek, M; Ketels, KV; Ratajczak, HV; Thomas, PT, 1987
)
0.27
" The acute effects of two carbamates (carbaryl, aldicarb) and five organophosphates (OP) (chlorpyrifos, diazinon, parathion, fenthion, and diisopropyl fluorophosphate, or DFP) were evaluated on the day of dosing at the time of peak effect, at 1 and 3 days, and 1 week after dosing (oral gavage, in corn oil)."( Comparisons of the acute effects of cholinesterase inhibitors using a neurobehavioral screening battery in rats.
Moser, VC,
)
0.13
" Dosing was through voluntary consumption of drinking water."( Endocrine, immune, and behavioral effects of aldicarb (carbamate), atrazine (triazine) and nitrate (fertilizer) mixtures at groundwater concentrations.
Carlson, IH; Jaeger, JW; Porter, WP,
)
0.13
" The dose-response data for brain ChE inhibition followed a similar pattern of age-related differences, and similar levels of inhibition were measured at the MTD regardless of age."( Comparison of aldicarb and methamidophos neurotoxicity at different ages in the rat: behavioral and biochemical parameters.
Moser, VC, 1999
)
0.3
" The neuropharmacologic effects of chronic dosing with aldicarb, AChE inhibition and dopaminergic modulation could be useful for treatment of memory deficits related to CNS disorders."( Neurochemical and behavioural effects of chronic aldicarb administration in rats.
Bacchi, S; Coppolino, MF; Palumbo, G; Pantaleoni, GC, 2001
)
0.31
" Survival times in the majority of rats dosed with aldicarb and receiving intravenous cyclodextrin were longer compared with the control rats only dosed with aldicarb per os."( Evaluation of hydroxypropyl-beta-cyclodextrin in the treatment of aldicarb poisoning in rats.
Botha, CJ; Verster, RS, 2004
)
0.32
" A significant increase in flight times of birds dosed with aldicarb and with chlorpyrifos was observed."( Effects of chlorpyrifos and aldicarb on flight activity and related cholinesterase inhibition in homing pigeons, Columba livia: potential for migration effects.
Moye, JK; Pritsos, CA, 2010
)
0.36
" The typical clinical picture can be confirmed by the dosage of plasma cholinesterases."( [Acute voluntary poisoning by carbamate].
Ghuysen, A; Van Brussel, E, 2014
)
0.4
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (15)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, TYROSYL-DNA PHOSPHODIESTERASEHomo sapiens (human)Potency10.00000.004023.8416100.0000AID485290
acetylcholinesteraseHomo sapiens (human)Potency14.71710.002541.796015,848.9004AID1347395; AID1347397; AID1347398; AID1347399
pregnane X receptorRattus norvegicus (Norway rat)Potency50.11870.025127.9203501.1870AID651751
GLI family zinc finger 3Homo sapiens (human)Potency28.12740.000714.592883.7951AID1259369; AID1259392
AR proteinHomo sapiens (human)Potency25.66510.000221.22318,912.5098AID588515; AID588516
nuclear receptor subfamily 1, group I, member 3Homo sapiens (human)Potency27.55610.001022.650876.6163AID1224838
progesterone receptorHomo sapiens (human)Potency27.55610.000417.946075.1148AID1346784
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency54.98170.003041.611522,387.1992AID1159552; AID1159555
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency51.46050.001530.607315,848.9004AID1224841; AID1259401
pregnane X nuclear receptorHomo sapiens (human)Potency50.42040.005428.02631,258.9301AID1346982; AID720659
peroxisome proliferator activated receptor gammaHomo sapiens (human)Potency39.81070.001019.414170.9645AID588537
vitamin D (1,25- dihydroxyvitamin D3) receptorHomo sapiens (human)Potency44.66840.023723.228263.5986AID588541
aryl hydrocarbon receptorHomo sapiens (human)Potency39.81070.000723.06741,258.9301AID651777
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency40.07740.000627.21521,122.0200AID651741; AID720636
Nuclear receptor ROR-gammaHomo sapiens (human)Potency1.18830.026622.448266.8242AID651802
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (13)

Processvia Protein(s)Taxonomy
negative regulation of transcription by RNA polymerase IINuclear receptor ROR-gammaHomo sapiens (human)
xenobiotic metabolic processNuclear receptor ROR-gammaHomo sapiens (human)
regulation of glucose metabolic processNuclear receptor ROR-gammaHomo sapiens (human)
regulation of steroid metabolic processNuclear receptor ROR-gammaHomo sapiens (human)
intracellular receptor signaling pathwayNuclear receptor ROR-gammaHomo sapiens (human)
circadian regulation of gene expressionNuclear receptor ROR-gammaHomo sapiens (human)
cellular response to sterolNuclear receptor ROR-gammaHomo sapiens (human)
positive regulation of circadian rhythmNuclear receptor ROR-gammaHomo sapiens (human)
regulation of fat cell differentiationNuclear receptor ROR-gammaHomo sapiens (human)
positive regulation of DNA-templated transcriptionNuclear receptor ROR-gammaHomo sapiens (human)
adipose tissue developmentNuclear receptor ROR-gammaHomo sapiens (human)
T-helper 17 cell differentiationNuclear receptor ROR-gammaHomo sapiens (human)
regulation of transcription by RNA polymerase IINuclear receptor ROR-gammaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (10)

Processvia Protein(s)Taxonomy
RNA polymerase II cis-regulatory region sequence-specific DNA bindingNuclear receptor ROR-gammaHomo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificNuclear receptor ROR-gammaHomo sapiens (human)
DNA-binding transcription repressor activity, RNA polymerase II-specificNuclear receptor ROR-gammaHomo sapiens (human)
DNA-binding transcription factor activityNuclear receptor ROR-gammaHomo sapiens (human)
protein bindingNuclear receptor ROR-gammaHomo sapiens (human)
oxysterol bindingNuclear receptor ROR-gammaHomo sapiens (human)
zinc ion bindingNuclear receptor ROR-gammaHomo sapiens (human)
ligand-activated transcription factor activityNuclear receptor ROR-gammaHomo sapiens (human)
sequence-specific double-stranded DNA bindingNuclear receptor ROR-gammaHomo sapiens (human)
nuclear receptor activityNuclear receptor ROR-gammaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (4)

Processvia Protein(s)Taxonomy
nucleusNuclear receptor ROR-gammaHomo sapiens (human)
nucleoplasmNuclear receptor ROR-gammaHomo sapiens (human)
nuclear bodyNuclear receptor ROR-gammaHomo sapiens (human)
chromatinNuclear receptor ROR-gammaHomo sapiens (human)
nucleusNuclear receptor ROR-gammaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (11)

Assay IDTitleYearJournalArticle
AID1192962Inhibition of recombinant Anopheles gambiae AChE G119S mutant compound incubated for up to 60 mins at approximately 10 mins interval2015Bioorganic & medicinal chemistry, Mar-15, Volume: 23, Issue:6
3-Oxoisoxazole-2(3H)-carboxamides and isoxazol-3-yl carbamates: Resistance-breaking acetylcholinesterase inhibitors targeting the malaria mosquito, Anopheles gambiae.
AID1192960Resistant ratio of LC50 for Anopheles gambiae Akron (MRA-913) to LC50 for Anopheles gambiae G3 (MRA-112)2015Bioorganic & medicinal chemistry, Mar-15, Volume: 23, Issue:6
3-Oxoisoxazole-2(3H)-carboxamides and isoxazol-3-yl carbamates: Resistance-breaking acetylcholinesterase inhibitors targeting the malaria mosquito, Anopheles gambiae.
AID977602Inhibition of sodium fluorescein uptake in OATP1B3-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID977599Inhibition of sodium fluorescein uptake in OATP1B1-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID1192964Selectivity ratio of Ki for recombinant wild-type Anopheles gambiae AChE to Ki for recombinant Anopheles gambiae AChE G119S mutant2015Bioorganic & medicinal chemistry, Mar-15, Volume: 23, Issue:6
3-Oxoisoxazole-2(3H)-carboxamides and isoxazol-3-yl carbamates: Resistance-breaking acetylcholinesterase inhibitors targeting the malaria mosquito, Anopheles gambiae.
AID1192957Tarsal contact toxicity in Anopheles gambiae Akron (MRA-913) assessed as mortality measured at 24 hrs by filter paper assay2015Bioorganic & medicinal chemistry, Mar-15, Volume: 23, Issue:6
3-Oxoisoxazole-2(3H)-carboxamides and isoxazol-3-yl carbamates: Resistance-breaking acetylcholinesterase inhibitors targeting the malaria mosquito, Anopheles gambiae.
AID1192963Inhibition of recombinant human AChE2015Bioorganic & medicinal chemistry, Mar-15, Volume: 23, Issue:6
3-Oxoisoxazole-2(3H)-carboxamides and isoxazol-3-yl carbamates: Resistance-breaking acetylcholinesterase inhibitors targeting the malaria mosquito, Anopheles gambiae.
AID1192955Tarsal contact toxicity in Anopheles gambiae G3 (MRA-112) assessed as mortality measured at 24 hrs by filter paper assay2015Bioorganic & medicinal chemistry, Mar-15, Volume: 23, Issue:6
3-Oxoisoxazole-2(3H)-carboxamides and isoxazol-3-yl carbamates: Resistance-breaking acetylcholinesterase inhibitors targeting the malaria mosquito, Anopheles gambiae.
AID1192961Inhibition of recombinant wild-type Anopheles gambiae AChE compound incubated for up to 6 min at approximately 1 min interval2015Bioorganic & medicinal chemistry, Mar-15, Volume: 23, Issue:6
3-Oxoisoxazole-2(3H)-carboxamides and isoxazol-3-yl carbamates: Resistance-breaking acetylcholinesterase inhibitors targeting the malaria mosquito, Anopheles gambiae.
AID1112896Displacement of [3H]-methyl-SFX from nAChR in Myzus persicae (green peach aphid) 4106A membrane at 1 ppm after 70 min2013Pest management science, May, Volume: 69, Issue:5
Investigating the mode of action of sulfoxaflor: a fourth-generation neonicotinoid.
AID1159550Human Phosphogluconate dehydrogenase (6PGD) Inhibitor Screening2015Nature cell biology, Nov, Volume: 17, Issue:11
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (364)

TimeframeStudies, This Drug (%)All Drugs %
pre-199088 (24.18)18.7374
1990's88 (24.18)18.2507
2000's80 (21.98)29.6817
2010's92 (25.27)24.3611
2020's16 (4.40)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews13 (3.27%)6.00%
Case Studies26 (6.53%)4.05%
Observational0 (0.00%)0.25%
Other359 (90.20%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]